Hyaluronic Acid
Dermal Filler with
Lidocaine
WHERE QUALITY MEETS PRECISION!
Hyaluronic Acid Dermal Filler with Lidocaine
WHERE QUALITY MEETS PRECISION!
MADE IN KOREA
Perfect monophasic
filler with lidocaine
why novafill
NATURAL LOOK
Novafill filler delivers a natural appearance by seamlessly blending with surrounding tissue, enhancing features while maintaining authenticity.
LONG-LASTING
Novafill offers enduring results, maintaining volume and effects over time, reducing the need for frequent touch-ups.
VISCOELASTICITY
Novafill’s balanced viscosity and elasticity mitigate gel migration concerns, allowing for smooth tissue adjustment and minimizing complications.
PRECISE INJECTION
With Novafill, injections are precise, ensuring accurate placement for optimal results with minimal discomfort.
EXCELLENT ADHESIVENESS
Novafill exhibits superior adhesion, providing stability and minimizing the risk of migration or displacement for reliable outcomes.
PROVEN SAFETY
Prioritizing safety, our product is backed by rigorous research and testing, ensuring a trusted, safe experience for patients and practitioners.
Cohesive
The gel’s capacity to adhere together, maintaining its structural integrity.
ELASTICITY
The gel’s ability to revert to its original form after experiencing deformation.
PLASTICITY
The gel’s flexibility to be shaped and molded.
The “Storage Modulus (G’)” for a filler refers to the elastic component of the complex modulus, which characterizes the material’s ability to store elastic energy when subjected to deformation. It’s a measure of the material’s stiffness or rigidity.
Novafill Fine
Depth of injection: Superficial Dermis
Syringe Volume: 1.1 m
Needles: 2 x 30G
Monophasic Cross-linked HA 24 mg/ml with 0.3 Lidocaine
Duration
3-6 months
Shelf Life
36 Months
The Ultra Thin Wall Needle features a larger inner diameter than regular needles, enhancing flow rates and reducing injection force.
Quality
Viscosity
Molding
Degree of Modification of HA
The NOVAFILL filler syringes feature an ergonomic design, ensuring even pressure distribution during
injection for precise and safe treatments.
| Fine |
Deep
Volume
|
||
|---|---|---|---|
| MOD | 1.8 |
2.6
4.26
|
|
This image illustrates the process of creating NOVAFILL, a cross-linked hyaluronic acid (HA)
dermal filler. The sequence depicted involves:
Free HA:
Initially, free hyaluronic acid is shown as a tangled network of individual polymer chains.
BDDE:
The next step introduces BDDE (1,4-Butanediol diglycidyl ether), a cross-linking agent.
Cross-Linking:
The BDDE cross-links the free HA, forming a macromolecular network. This network structure enhances the stability and longevity of the HA.
Particle Creation:
Finally, the cross-linked HA network is processed into particles, resulting in the formation of NOVAFILL, a stable and effective dermal filler. The cross-linking process is crucial for creating a gel that maintains its integrity, shape, and viscoelastic properties, making NOVAFILL an excellent choice for cosmetic and medical applications.
Complete removal of BDDE.
The purified product reduces side effects by
eliminating unreacted materials. BDDE residue is
below standard levels, resulting in a low risk of
allergies and hypersensitivity.
The residue should not exceed 2ppm. However, in NOVAFILL fillers, the BDDE residue is
undetectable, making it one of the safest and most reliable products on the market.
| Specifications | Official Standard |
Novafill Standard
|
|
|---|---|---|---|
| BDDE residue | under 2 ppm |
0
|
|
